Idiopathic short stature (ISS) describes a condition where children have a height more than two standard deviations below the mean for average stature population for age and gender, where known causes of short stature have been excluded.
Learn more about our ISS clinical trials below.
A Multicenter, Observational Study to Characterize Growth in Children with Idiopathic Short Stature
A Multicenter, Observational Study to Characterize Growth in Children with Idiopathic Short Stature
This study will generate baseline growth data in children with ISS by collecting growth measurements and other variables of interest.
N/A
This study is currently recruiting participants
Observational
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH), in children with idiopathic short stature (ISS).
Vosoritide
Not yet recruiting
Interventional